Author Details
Ihara, Shouichi, Department of Respiratory Medicine, Osaka Police Hospital, 10-31 Kitayama-cho, Tennoji-ku, Osaka 543-0035, Japan
-
Vol. 8, No. 6, Dec 2017 - Original Article
Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival of Advanced Non-Small Cell Lung Cancer Harboring Mutant Epidermal Growth Factor Receptor
Abstract
HTML
PDF
-
Vol. 9, No. 1, Feb 2018 - Original Article
Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation
Abstract
HTML
PDF
-
Vol. 10, No. 1, Feb 2019 - Original Article
Pretreatment Lung Immune Prognostic Index Is a Prognostic Marker of Chemotherapy and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Abstract
HTML
PDF
-
Vol. 10, No. 2, Apr 2019 - Original Article
Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer
Abstract
HTML
PDF
-
Vol. 11, No. 1, Feb 2020 - Original Article
Sarcopenia and Visceral Adiposity Did Not Affect Efficacy of Immune-Checkpoint Inhibitor Monotherapy for Pretreated Patients With Advanced Non-Small Cell Lung Cancer
Abstract
HTML
PDF
Suppl1
Suppl2
Suppl3
-
Vol. 10, No. 6, Dec 2019 - Original Article
Low Body Mass Index Is an Independent Prognostic Factor in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Abstract
HTML
PDF
-
Vol. 11, No. 3, Jun 2020 - Original Article
Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Prognostic Markers for Extensive Disease of Small Cell Lung Cancer
Abstract
HTML
PDF